Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
824.00    6.00 (0.73%)
Bid:
820.00
Ask:
824.00
Spread: 4.00 (0.488%)
Market Cap: £8.24b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Half-year Report

29 Nov 2021 14:38

RNS Number : 9227T
Wise PLC
29 November 2021
 

Wise plc

29 November 2021

 

Release of unaudited historic financial information

 

Wise is today releasing selected historic consolidated financial statements on an unaudited half yearly basis for the year ended 31 March 2021.

 

 

Enquiries

Martin Adams - Head of Owner Relations

martin.adams@wise.com

 

 

Condensed consolidated statement of comprehensive income (unaudited)

 

 

Year ended

Half-year ended

Half-year ended

£m (unless otherwise noted)

31 March 2021

30 September 2020

31 March 2021

Revenue

421.0

192.2

228.8

Cost of sales

(151.7)

(71.8)

(79.9)

Net credit losses on financial assets

(8.8)

(1.2)

(7.6)

Gross profit

260.5

119.2

141.3

Administrative expenses

(217.5)

(97.6)

(119.9)

Interest income from investments and operating assets

1.9

1.0

0.9

Interest expense from operating assets

(3.8)

(1.6)

(2.2)

Other income

3.8

1.1

2.7

Operating profit

44.9

22.1

22.8

Finance expense

(3.8)

(2.1)

(1.7)

Profit before tax

41.1

20.0

21.1

Income tax expense

(10.2)

(5.4)

(4.8)

Profit for the period

30.9

14.6

16.3

Other comprehensive income

Items that may be reclassified to profit or loss:

Fair value (loss)/gain on investments

(3.0)

0.2

(3.2)

Currency translation differences

(3.8)

0.3

(4.1)

Total other comprehensive (loss)/income

(6.8)

0.5

(7.3)

Total comprehensive income for the period

24.1

15.1

9.0

 

 

 

Condensed consolidated statement of financial position (unaudited)

 

 

As at 31 March

As at 30 September

As at 31 March

£m

2020

2020

2021

Non-current assets

Deferred tax assets

32.0

38.7

56.7

Property, plant and equipment

19.1

16.7

24.0

Intangible assets

21.3

24.4

27.5

Trade and other receivables

7.6

8.3

15.1

Total non-current assets

80.0

88.1

123.3

Current assets

Current tax assets

2.1

1.7

1.1

Trade and other receivables

102.6

89.2

81.3

Short-term financial investments

114.1

289.3

737.5

Cash and cash equivalents

2,077.6

2,872.1

3,358.6

Total current assets

2,296.4

3,252.3

4,178.5

Total assets

2,376.4

3,340.4

4,301.8

Non-current liabilities

Deferred tax liabilities

-

-

2.0

Non-current borrowings

59.6

9.0

95.2

Non-current trade and other payables

7.4

9.5

22.6

Total non-current liabilities

67.0

18.5

119.8

Current liabilities

Borrowings

4.2

28.3

3.5

Current tax liabilities

0.7

0.8

2.0

Trade and other payables

2,107.7

3,051.2

3,891.2

Total current liabilities

2,112.6

3,080.3

3,896.7

Total liabilities

2,179.6

3,098.8

4,016.5

Equity

Share capital

9.4

9.4

9.4

Equity merger reserve

111.1

112.0

(8.0)

Share-based payment reserves

63.8

90.0

124.5

Own shares reserve

-

-

-

Other reserves

2.3

2.5

(0.7)

Retained earnings

8.9

26.1

162.6

Currency translation differences

1.3

1.6

(2.5)

Total equity

196.8

241.6

285.3

Total liabilities and equity

2,376.4

3,340.4

4,301.8

 

 

Condensed consolidated statement of cash flows (unaudited)

 

 

 

£m

Year ended

Half-year ended

Half-year ended

31 March 2021

30 September 2020

31 March 2021

Cash flows from operating activities

Cash generated from operations

2,076.3

1,012.0

1,064.3

Interest received

7.6

2.7

4.9

Interest expense paid

(6.0)

(2.7)

(3.3)

Corporate income tax paid

(4.0)

(0.8)

(3.2)

Net cash generated from operating activities

2,073.9

1,011.2

1,062.7

Cash flows from investing activities

Payments for property, plant and equipment

(2.3)

(1.1)

(1.2)

Payment for intangible assets

(20.9)

(10.1)

(10.8)

Payments for financial assets at FVOCI

(723.9)

(222.7)

(501.2)

Proceeds from sale and maturity of financial assets at FVOCI

75.3

41.1

34.2

Net cash used in investing activities

(671.8)

(192.8)

(479.0)

Cash flows from financing activities

Proceeds from issues of shares and other equity

0.9

0.9

-

Proceeds from borrowings

118.6

25.0

93.6

Repayments of borrowings

(90.0)

(50.0)

(40.0)

Payments for lease liabilities

(4.7)

(2.4)

(2.3)

Net cash generated from financing activities

24.8

(26.5)

51.3

Net increase in cash and cash equivalents

1,426.9

791.9

635.0

Cash and cash equivalents at beginning of the period

2,077.6

2,077.6

2,872.1

Effects of exchange rate changes on cash and cash equivalents

(145.9)

2.6

(148.5)

Cash and cash equivalents at end of the period

3,358.6

2,872.1

3,358.6

 

 

Condensed consolidated statement of changes in equity (unaudited)

 

 

£m

Share capital

Equity merger reserve

Share-based payment reserves

Own shares reserve

Other reserves

Retained earnings

Currency translation differences

Total equity

At 1 April 2020

9.4

111.1

63.8

-

2.3

8.9

1.3

196.8

Profit for the period

-

-

-

-

-

14.6

-

14.6

Fair value gain on investments

-

-

-

-

0.2

-

-

0.2

Foreign currency translation differences

-

-

-

-

-

-

0.3

0.3

Total comprehensive income for the period

-

-

-

-

0.2

14.6

0.3

15.1

Share-based employee compensation expense

-

-

18.0

-

-

-

-

18.0

Deferred tax on share-based compensation

-

-

10.8

-

-

-

-

10.8

Share options exercises

-

0.9

(2.6)

-

-

2.6

-

0.9

At 30 September 2020

9.4

112.0

90.0

-

2.5

26.1

1.6

241.6

Profit for the period

-

-

-

-

-

16.3

-

16.3

Fair value loss on investments

-

-

-

-

(3.2)

-

-

(3.2)

Foreign currency translation differences

-

-

-

-

-

-

(4.1)

(4.1)

Total comprehensive income for the period

-

-

-

-

(3.2)

16.3

(4.1)

9.0

Reduction of share capital

-

(120.0)

-

-

-

120.0

-

-

Share-based employee compensation expense

-

-

18.9

-

-

-

-

18.9

Deferred tax on share-based compensation

-

-

15.8

-

-

-

-

15.8

Share options exercises

-

-

(0.2)

-

-

0.2

-

-

At 31 March 2021

9.4

(8.0)

124.5

-

(0.7)

162.6

(2.5)

285.3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVSLSLAFIL
Date   Source Headline
22nd Jan 20244:07 pmRNSTotal Voting Rights
22nd Jan 20241:41 pmRNSDirector/PDMR Shareholding
18th Jan 20241:16 pmRNSDirector/PDMR Shareholding
17th Jan 20242:08 pmRNSDirector/PDMR Shareholding
16th Jan 20241:44 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSWise Plc Q3FY24 Trading Update
8th Jan 20241:17 pmRNSHolding(s) in Company
3rd Jan 20242:37 pmRNSHolding(s) in Company
3rd Jan 20249:39 amRNSHolding(s) in Company
2nd Jan 202411:32 amRNSTotal Voting Rights
18th Dec 202310:19 amRNSTotal Voting Rights
4th Dec 20232:50 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20231:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20232:29 pmRNSDirector/PDMR Shareholding
22nd Nov 202312:46 pmRNSDirector/PDMR Shareholding
21st Nov 202312:24 pmRNSDirector/PDMR Shareholding
17th Nov 20231:41 pmRNSDirector/PDMR Shareholding
16th Nov 20239:56 amRNSDirector/PDMR Shareholding
15th Nov 20231:52 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSWise Plc HY FY24 Unaudited Interim Results
10th Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 20232:18 pmRNSTotal Voting Rights
1st Nov 20232:15 pmRNSDirector/PDMR Shareholding
17th Oct 20233:16 pmRNSDirector/PDMR Shareholding
13th Oct 20234:26 pmRNSDirector/PDMR Shareholding
12th Oct 20237:09 amRNSWise Plc Q2FY24 Trading Statement
2nd Oct 20234:56 pmRNSTotal Voting Rights
18th Sep 20239:00 amRNSBoard Committee Updates
7th Sep 20235:12 pmRNSResult of AGM
1st Sep 20239:04 amRNSTotal Voting Rights
18th Aug 20233:41 pmRNSDirector/PDMR Shareholding
18th Aug 20232:41 pmRNSDirector/PDMR Shareholding
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
11th Aug 20232:40 pmRNSTotal Voting Rights
10th Aug 20239:20 amRNSBlock listing Interim Review
9th Aug 20232:07 pmRNSHolding(s) in Company
8th Aug 20232:08 pmRNSDirector/PDMR Shareholding
8th Aug 20231:03 pmRNSDirector/PDMR Shareholding (Replacement)
4th Aug 202310:37 amRNSDirector/PDMR Shareholding
1st Aug 20232:43 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSTotal Voting Rights
31st Jul 20238:16 amRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSNotice of AGM
25th Jul 202312:27 pmRNSDirector/PDMR Shareholding
20th Jul 20231:24 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 202311:35 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.